期刊文献+

生长激素、脑利钠肽和肾上腺髓质素在心力衰竭中的变化及其临床意义

Change and significance of growth hormone,brain natriuretic peptide and adrenomedullin in congestive heart failure
下载PDF
导出
摘要 目的通过观察不同病因所致充血性心力衰竭(CHF)患者血清生长激素(GH)、脑利钠肽(BNP)和血浆肾上腺髓质素(ADM)的水平变化,比较三者在CHF中的诊断价值及其灵敏度和特异度。方法将受试对象分为非心力衰竭组30例和心力衰竭组72例。心力衰竭组中冠心病31例,高血压病12例,风湿性心脏病16例,扩张型心肌病13例。其中NYHA心功能分级Ⅱ级组22例,Ⅲ级组20例,Ⅳ级组30例。分别用放射免疫法和酶联免疫法测定血浆ADM、血清BNP和GH的浓度,同时行心脏彩色多普勒超声测定左室舒张末内径(LVED)和左室射血分数(LVEF)。结果心力衰竭组GH和BNP的水平较非心力衰竭组升高,分别是(0.83±1.06)μg/L vs(0.15±0.42)μg/L和(115.31±191.16)ng/L vs(33.51±49.85)ng/L(均P<0.01);ADM两组间比较,差异无统计学意义(P>0.05)。不同病因组间BNP和GH比较,差异无统计学意义(P>0.05)。不同心功能级别间BNP和GH比较,差异有统计学意义(P<0.05)。GH和BNP均与心功能级别呈正相关(P<0.001)。对GH和BNP的ROC曲线下面积做是否为0.5的假设检验,差异无统计学意义(均P<0.001)。BNP诊断心力衰竭的敏感度为89.3%,特异度为63.0%;GH诊断心力衰竭的灵敏度为85.7%,特异度为59.3%。BNP和GH联合使用,诊断心力衰竭的灵敏度为75.0%,特异度为74.0%。结论GH和BNP有助于CHF的诊断,ADM对CHF的诊断价值不大;BNP诊断CHF的敏感度和特异度均优于GH;BNP与GH联合应用诊断心力衰竭好于二者单用。 Objective To evaluate the diagnostic value of growth hormone(GH) ,brain natriuretic peptide(BNP) and adrenomedullin(ADM),and contrast their sensitivity and specificity in the patients with congestive heart failure. Methods The blood samples were obtained from 72 patients with congestive heart failure(CHF) and 30 patients without CHF,and their serum/plasma levels of GH,BNP and ADM were measured by enzyme-labeled immunosorbent assay(ELISA) and radioimmunoassay. At the same time all the patients received colorful Doppler ultrasonocardiogram to determine left ventricular end-dilation diameter(LVED) and left ventricular ejection fraetion(LVEF). Results GH and BNP levels in CHF group were higher than those in non-CHF group(0.83±1.06)μg/L vs (0.15±0.42) μg/L and (115.31±191.16) ng/L vs (33.51 ± 49.85) ng/L, respectively(all P 〈0.01). ADM level was no statistical significance between CHF group and non-CHF group. GH and BNP had positive correlations to different classification of heart function( P 〈0. 001). A hypothesis test to the area under the receiver operating characteristic(ROC) curve of BNP and GH showed statistic significance ( P 〈0. 001). The sensitivities and specificities of BNP were 89.3 % and 63.0%, those of GH were 85.7 % and 59.3%, BNP combined with GH were 75.0% and 74.0 %. Conclusion GH and BNP can help to establish the diagnosis of different classification of heart function. ADM is not helpful to the diagnosis of CHF. The sensitivity and specificity of BNP are better than those of GH. The combination of GH and BNP is better than the application alone in the diagnosis of CHF.
出处 《临床荟萃》 CAS 北大核心 2007年第17期1219-1222,共4页 Clinical Focus
关键词 心力衰竭 充血性 生长激素 利钠肽 heart failure, congestive growth hormone natriuretic peptide, brain
  • 相关文献

参考文献7

二级参考文献38

  • 1赵东,田青,赵云涛,宫长宁,韩启德,张肇康,汤健.肾上腺髓质素(13-52)降压机制的探讨[J].生理学报,1995,47(3):218-224. 被引量:18
  • 2石湘芸,张昭馥,赵云涛,聂智群,田青,唐朝枢,汤健,张肇康.原发性高血压患者血浆肾上腺髓质素水平的初步观察[J].中华核医学杂志,1996,16(4):266-267. 被引量:15
  • 3Ishii J, Nomura M, Nakamura Y, et al. Risk Stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol,2002, 89 : 691--695.
  • 4Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med, 1998, 339:321--328.
  • 5Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (NBNP) concentrations. The Lancet, 2000, 355:1126--1130.
  • 6Hara Y, Hamada M, Shigematsu Y, et al. Effect of Beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor.Japanese Circulation Journal, 2000, 64 : 365--369.
  • 7Morita E, Yasue H, Ycxshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993, 88:82--91.
  • 8Choy AMJ, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acut myocardial infarction comparison of clinical,echocardiographic, and neurohormonal methods. Br Heart J, 1994,72 : 16--22.
  • 9Tsutamoto T, Wada A, Maeda K, et al. Plasma brain natriuretic peptide level as a biochemical maker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart, 1999, 20:1799--1807.
  • 10Clerico A, Lervasi G, Mariani G. Pathophysiologic relevance of measuring the plasma levels of cardiac natriuretic peptide hormones in humans.Horm Metab Res, 1999, 31:487--498.

共引文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部